AbbVie Reports Promising Clinical Updates, Dividend Outlook
AbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
What Age Should You Start Planning For Retirement
Wondering what age you should start planning for retirement? Discover key insights that will help you prepare for a secure financial future.
25,645 articles
Devices (Mass) 2025 Earnings: MASS Stock Outlook and Risk
Unpack the essential takeaways from MASS's hypothetical Q4 2025 earnings. Learn how to read the transcript, spot marg...
Reasons Into Hantavirus-Related Biotech: 3 Cautions
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Rice Hall James Buys QuidelOrtho Stock: A Deep Dive Into It
A notable stake from an experienced manager in a healthcare diagnostics stock signals a thoughtful, long term thesis....
Rivian Faces Biggest Short-Term Threat: What Investors Need to Know
Rivian has captured imaginations—and capital. But the next 12 months will test its ability to scale, control costs, a...
Investor Buys Million Enviri as Stock Surges 100% in a Year
A large institutional stake in Enviri sparks questions about the company’s trajectory. This article breaks down what ...
SaaSpocalypse Isn’t Killing Software: What It Means Now
A February market shock erased roughly $285B in software valuations, forcing a rethink of what truly drives software ...
Hedge Fund Boone Capital Stake in HealthEquity: Is It a Buy?
Boone Capital just disclosed a fresh position in HealthEquity, raising questions about the stock's potential. This gu...
Astera Labs Stock Roaring: Why It's Breaking Out This Week
Astera Labs has captured investor attention with a strong rally. This article dives into the reasons behind the move,...
Will Tilray Brands' Diversification: Will It Pay Off for Investors?
Tilray Brands is expanding beyond its cannabis roots into beverages and other segments. This article examines whether...
What Know About This Fund's $65 Million Homebuilder Bet Before a $47-Per-Share Buyout
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status